TELUS International (Cda) Inc. (NYSE:TIXT) Forecast To Rise 44.55% To Reach Consensus Target Price
TELUS International (Cda) Inc (NYSE:TIXT) has a beta value of 0.73 and has seen 0.28 million shares traded in the last trading session. The company,
TELUS International (Cda) Inc (NYSE:TIXT) has a beta value of 0.73 and has seen 0.28 million shares traded in the last trading session. The company,
Prelude Therapeutics Inc (NASDAQ:PRLD) has a beta value of 1.53 and has seen 0.2 million shares traded in the last trading session. The PRLD stock
Adc Therapeutics SA (NYSE:ADCT) has a beta value of 1.60 and has seen 0.29 million shares traded in the last trading session. The company, currently
VivoPower International PLC (NASDAQ:VVPR) has a beta value of 2.85 and has seen 0.12 million shares traded in the last trading session. The company, currently
I-Mab ADR (NASDAQ:IMAB) has a beta value of 1.08 and has seen 0.21 million shares traded in the last trading session. The company, currently valued
Cosmos Health Inc (NASDAQ:COSM) has a beta value of 3.14 and has seen 93485.0 shares traded in the last trading session. The company, currently valued
Aeva Technologies Inc (NYSE:AEVA) has seen 0.14 million shares traded in the last trading session. The company, currently valued at $177.04M, closed the last trade
Air Industries Group (AMEX:AIRI) has a beta value of 0.29 and has seen 0.13 million shares traded in the last trading session. The company, currently
Alto Neuroscience Inc. (NYSE:ANRO) has seen 0.18 million shares traded in the last trading session. The company, currently valued at $345.36M, closed the last trade
Design Therapeutics Inc (NASDAQ:DSGN) has a beta value of 1.83 and has seen 98051.0 shares traded in the last trading session. The company, currently valued
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.